Roger Medel MD - 27 Dec 2021 Form 4 Insider Report for MEDNAX, INC. (MD)

Role
Director
Signature
/s/ Dominic J. Andreano, Attorney-in-Fact
Issuer symbol
MD
Transactions as of
27 Dec 2021
Net transactions value
-$3,713,145
Form type
4
Filing time
29 Dec 2021, 16:31:38 UTC
Previous filing
29 Oct 2021
Next filing
30 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Sale $1,816,804 -66,868 -5.9% $27.17 1,060,925 27 Dec 2021 Direct F1, F2
transaction MD Common Stock Sale $1,214,342 -44,514 -4.2% $27.28 1,016,411 28 Dec 2021 Direct F1, F3
transaction MD Common Stock Sale $682,000 -25,000 -2.5% $27.28 991,411 29 Dec 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.84 to $27.48 for a weighted average sales price of $27.17. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $27.15 to $27.71 for a weighted average sales price of $27.28. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.98 to $27.43 for a weighted average sales price of $27.28. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.